SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "L773:1934 8800 OR L773:0163 6383 OR L773:1879 0453 srt2:(2005-2009)"

Search: L773:1934 8800 OR L773:0163 6383 OR L773:1879 0453 > (2005-2009)

  • Result 1-3 of 3
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Fagard, Jacqueline, et al. (author)
  • Reaching and grasping a moving object in 6-, 8-, and 10-month-old infants : Laterality and performance
  • 2009
  • In: Infant Behavior and Development. - : Elsevier BV. - 0163-6383 .- 1879-0453. ; 32:2, s. 137-146
  • Journal article (peer-reviewed)abstract
    • The goal of this study was to investigate some of the visuo-motor factors underlying an infant's developing ability to grasp a laterally-moving object. In particular, hand preference, midline crossing, and visual-field asymmetry were investigated by comparing performance as a function of the object's direction of motion. We presented 6-, 8-, and 10-month-old infants with a graspable object, moving in a circular trajectory in the horizontal plane. Six-month-old infants reached for the object with the ipsilateral hand and grasped it with the contralateral hand. Eight-month-old infants showed a strong right-hand bias for both reaching and grasping. Ten-month-old infants showed a greater diversity of strategy use including bimanual and successful ipsilateral grasping following ipsilateral reaching in both directions of motion. Thus, motor constraints due to spatial compatibility, hand preference and bimanual coordination (but not midline crossing) must be taken into account to understand age differences in grasping a moving object.
  •  
2.
  • Strid, Karin, 1974, et al. (author)
  • Infant recall memory and communication predicts later cognitive development
  • 2006
  • In: Infant Behavior and Development. - : Elsevier BV. - 0163-6383 .- 1879-0453. ; 29:4, s. 545-553
  • Journal article (peer-reviewed)abstract
    • This longitudinal study investigates the relation between recall memory and communication in infancy and later cognitive development. Twenty-six typically developing Swedish children were tested during infancy for deferred imitation (memory), joint attention (JA), and requesting (nonverbal communication), they also were tested during childhood for language and cognitive competence. Results showed that infants with low performance on both deferred imitation at 9 months and joint attention at 14 months obtained a significantly lower score on a test of cognitive abilities at 4 years of age. This long-term prediction from preverbal infancy to childhood cognition is of interest both to developmental theory and to practice. © 2006 Elsevier Inc. All rights reserved.
  •  
3.
  • Dormandy, J. A., et al. (author)
  • Impact of peripheral arterial disease in patients with diabetes : results from PROactive (PROactive 11)
  • 2009
  • In: Atherosclerosis. - Amsterdam : Elsevier. - 0021-9150 .- 1879-1484. ; 202:1, s. 272-281
  • Journal article (peer-reviewed)abstract
    • We compared cardiovascular disease outcomes according to the presence of peripheral arterial disease (PAD) at baseline in a post hoc analysis from the PROactive study. Of the 5238 patients in PROactive (a study of pioglitazone versus placebo in patients with type 2 diabetes and macrovascular disease; mean follow-up=34.5 months), 1274 had PAD at baseline (619=pioglitazone; 655=placebo). Patients with PAD at baseline showed significantly higher rates of the primary endpoint, main secondary endpoint, all-cause mortality (all P<0.0001), and stroke (P=0.0175) than those with no PAD at baseline. The risk of PAD alone was similar to that of myocardial infarction alone. In patients with no PAD at baseline, the event rates of the primary endpoint (P=0.0160), main secondary endpoint (P=0.0453), and acute coronary syndrome (P=0.0287) were significantly lower with pioglitazone than with placebo. This beneficial effect of pioglitazone was not seen in patients with PAD at baseline. In the total population, there was a higher frequency of leg revascularizations with pioglitazone than placebo-this was wholly due to first events that occurred within the initial 12 months of treatment. The presence of PAD increased the risk of all major cardiovascular events. Those without PAD at baseline seemed to benefit more from pioglitazone treatment than the overall PROactive population.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-3 of 3

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view